公开(公告)号：US11311520B2

公开(公告)日：2022-04-26

申请号：US16983768

申请日：2020-08-03

申请人： Bayer Pharma Aktiengesellschaft ,  Bayer Aktiengesellschaft

发明人： Ulrich Klar ,  Rolf Bohlmann ,  Heike Schäcke ,  Detlev Sülzle ,  Stephan Menz ,  Olaf Panknin

IPC分类号： C07D471/04 ,  A61K31/437 ,  A61K31/5386 ,  C07D473/34 ,  C07D495/04 ,  C07D495/14 ,  C07D498/08 ,  C07D513/04 ,  C07D519/00

摘要： The present invention relates to substituted dihydroimidazopyridinedione compounds of general formula (I) as described and defined herein, to methods of preparing said compounds, to intermediate compounds useful for preparing said compounds, to pharmaceutical compositions and combinations comprising said compounds and to the use of said compounds for manufacturing a pharmaceutical composition for the treatment or prophylaxis of a disease, in particular of a hyperproliferative, angiogenesis disorders, inflammatory diseases or diseases associated with inflammatory pain, as a sole agent or in combination with other active ingredients.